SNOW has navigated two earnings events in the span of a week, and the data now shows a stock where analysts and the market are pulling in opposite directions — the Street has never been more unified, yet the price keeps drifting lower.
The analyst picture has only grown more emphatic. Every firm that touched the name in the past two weeks moved targets higher without exception. Cantor Fitzgerald leads the fresh cluster at $405, followed by Citigroup and BofA at $395. A broader group spanning Baird, Benchmark, Mizuho, TD Cowen, and Truist set targets in the $350–$375 range, while Barclays — the most cautious holdout — still lifted its Equal-Weight target to $332. That unanimity is rare. The consensus mean now prints at $331.66, but given that most of the laggard estimates haven't yet refreshed, the effective centre of gravity for active analysts is well above $350. Forward EPS momentum ranks in the 84th percentile year-on-year, with the 90-day EPS score at 75. The bull case rests on cloud data platform disruption and AI-workload acceleration; the bear case names AWS, Azure, and Databricks as structural threats, and flags a P/E near 135x and EV/EBITDA near 87x as multiples that leave no room for execution misses. That valuation tension is real — the price-to-book has risen roughly 13% over the past month alongside the stock's 9% monthly gain.
Positioning is notably relaxed, and that cuts both ways. Short interest has retreated 13% over the past month to 5.3% of the free float — roughly 18 million shares — with the weekly pace of unwinding continuing at around 2.6%. Borrow availability is extraordinarily loose, with lenders holding more than twenty-two times the shares currently out on loan. Cost to borrow has eased 15% on the week to just 0.39%, a multi-month low. The ORTEX short score is a neutral 40.3, sitting in the 38th percentile of its range. Options confirm the absence of urgency: the put/call ratio at 0.80 is essentially flat against its 20-day mean of 0.80, a z-score of near-zero. There is no defensive hedging spike, no borrow squeeze, and no short-seller conviction surge — the positioning picture is, in a word, calm.
The insider data provides the one note of friction. Director Benoit Dageville, a Snowflake co-founder, sold 50,000 shares on August 26 for approximately $15.5 million — all under a pre-arranged 10b5-1 plan. EVP Christian Kleinerman also liquidated roughly $9 million worth of shares at $300 in late July, also plan-driven. The 90-day insider net across all open-market transactions is negative $38.5 million. Planned sales carry less signal than discretionary ones, but the scale is worth noting: co-founder selling at these volumes, even pre-scheduled, lands at the same moment the stock is testing new year-to-date highs. BlackRock, meanwhile, has been moving the other way — its 13G/A filing in late July showed a stake rise from 5.02% to 6.4%, adding more than 3.4 million shares. T. Rowe Price added over 5.7 million shares in its most recent disclosure. The institutional flow and the insider flow are pointed in opposite directions.
Tuesday's 3.5% drop to $319.80 landed the stock below most of the fresh analyst targets and close to Barclays' Equal-Weight line at $332, suggesting the market's response to the second print is more measured than the analyst community's. Peer moves on the day were uniformly negative — MDB fell 4.2%, OKTA dropped 3.8%, NET slid 6.4% — pointing to broad-based cloud software pressure rather than a SNOW-specific reaction. The question the data now frames — without resolving — is whether the gap between the Street's upgraded targets and the market's cooling response is a buying opportunity or a lag in analyst price discovery.
See the live data behind this article on ORTEX.
Open SNOW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
